Semaglutide Superior to Liraglutide for Weight Loss
FRIDAY, Jan. 21, 2022 (HealthDay News) -- Among adults with overweight or obesity, once-weekly subcutaneous semaglutide plus counseling for diet and physical activity results in significantly greater weight loss at 68 weeks than once-daily subcutaneous liraglutide, according to a study published in the Jan. 11 issue of the Journal of the American Medical Association.
Domenica M. Rubino, M.D., from the Washington Center for Weight Management and Research in Arlington, Virginia, and colleagues compared the efficacy and adverse event profiles of once-weekly subcutaneous semaglutide (126 patients) versus once-daily subcutaneous liraglutide (127 patients) or placebo (85 patients) in people with overweight or obesity also undertaking diet and physical activity and followed for 68 weeks.
The researchers found that participants had significantly greater odds of achieving ≥10 percent, ≥15 percent, and ≥20 percent weight loss with semaglutide versus liraglutide (odds ratios, 6.3, 7.9, and 8.2, respectively). Discontinuation of treatment for any reason occurred in 13.5 percent with semaglutide and 27.6 percent with liraglutide. Gastrointestinal adverse events occurred in 84.1 percent with semaglutide and 82.7 percent with liraglutide.
"Whether semaglutide could be beneficial in preventing progression of cardiometabolic disease will be evaluated in the SELECT trial," the authors write.
Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which manufactures semaglutide and funded the trial.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Los hombres tienen más probabilidades que las mujeres de un sueño nocturno reparador
VIERNES, 20 de mayo de 2022 (HealthDay News) -- Para muchas mujeres, tenerlo...
Un estudio halló que el ejercicio es la clave para la pérdida de peso en las personas resistentes a las dietas
Was this page helpful?
Mental Health Impact of COVID-19 Pandemic Examined
TUESDAY, Oct. 18, 2022 (HealthDay News) -- There was an increase in the symptoms...
FDA Orders Stores to Stop Selling Elf Bar Disposable Vapes
FRIDAY, June 23, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...